HIGH PROLIFERATION (MCL35 ASSAY) IS ASSOCIATED WITH INFERIOR OUTCOMES IN PATIENTS TREATED WITH INTENSIVE REGIMENS—A CORRELATIVE STUDY FROM THE CALGB 50403 (ALLIANCE) TRIAL. (June 2017) - Scott, D.W.; Pitcher, B.; Liu, Y.; Boyle, M.; Mottok, A.; Said, J.; Chadburn, A.; Lai, R.; Jung, S.; Bartlett, N.L.; Leonard, J.P.; Kaplan, L.D.; et al.